Study of Novel Types 1 and 3 Oral Poliomyelitis Vaccines
Condition: Poliomyelitis Interventions: Biological: Novel Oral Polio Vaccine Type 1 (nOPV1); Biological: Novel Oral Polio Vaccine Type 3 (nOPV3); Biological: Sabin Monovalent Oral Polio Vaccine Type 1 (mOPV1); Biological: Sabin Monovalent Oral Polio Vaccine Type 3 (mOPV3) Sponsors: PATH; Bill and Melinda Gates Foundation; Centers for Disease Control and Prevention; Viroclinics Biosciences B.V.; The Emmes Company, LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials